← Mold

Hidden Mold

Why mold is far more common than people realize, how mycotoxins affect health, the symptoms that mimic other conditions, and how to find mold you can't see

You probably do not think of your home as a place where toxic fungi are quietly producing chemicals that can make you chronically ill. But there is a reasonable chance it is. Studies consistently find that roughly 50% of buildings in the United States and Europe have some evidence of water damage, and where there is water damage, there is almost certainly mold [1]. Most of it is hidden — behind walls, under flooring, inside HVAC systems — producing mycotoxins that circulate through indoor air and accumulate in dust, often without any visible sign that something is wrong.

More Common Than You Think

Mold is not a problem reserved for old houses or neglected buildings. Modern construction practices — tighter building envelopes, complex HVAC systems, materials like drywall that absorb and retain moisture — have in many ways made mold problems worse, not better. The WHO has estimated that dampness and mold affect 10-50% of indoor environments in Europe, North America, Australia, and Japan [1]. In the United States, the EPA and various surveys suggest the figure is on the higher end of that range.

The issue is that mold only needs three things to grow: moisture, an organic food source, and time. A slow leak behind a wall. Condensation inside an HVAC duct. A bathroom with inadequate ventilation. A one-time flood that was "dried out" but left moisture trapped in building materials. Any of these can establish a mold colony that grows for months or years without detection.

Mycotoxins: The Real Problem

Mold itself is a nuisance. Mycotoxins — the toxic secondary metabolites that many mold species produce — are the health concern. The major mycotoxins found in indoor environments include [2][3]:

  • Aflatoxins. Produced primarily by Aspergillus flavus and A. parasiticus. Classified as a Group 1 carcinogen by the International Agency for Research on Cancer. While most commonly associated with contaminated food (grains, nuts, spices), aflatoxin-producing Aspergillus species also grow in damp buildings.
  • Ochratoxin A. Produced by Aspergillus and Penicillium species. Nephrotoxic (kidney-damaging) and potentially carcinogenic. Found in indoor dust and air in water-damaged buildings, as well as in contaminated food and beverages including coffee and wine.
  • Trichothecenes. Produced by Stachybotrys chartarum (the infamous "black mold") and Fusarium species. Among the most toxic mycotoxins — they inhibit protein synthesis at the cellular level. Trichothecene-producing molds were the basis for a 2003 CDC investigation linking infant pulmonary hemorrhage to contaminated homes.
  • Gliotoxin. Produced by Aspergillus fumigatus. Immunosuppressive — it directly impairs white blood cell function, which may explain why mold-exposed individuals often develop recurrent infections.

Mycotoxins are remarkably stable. They survive temperature extremes, persist in dust for years, and can be inhaled, ingested, or absorbed through skin contact [3]. Killing the mold does not destroy the mycotoxins it has already produced — which is why remediation is more complex than simply spraying bleach on a visible colony.

Symptoms That Mimic Everything Else

One of the most frustrating aspects of mold illness is that its symptoms overlap with dozens of other conditions. People with chronic mold exposure frequently receive diagnoses of chronic fatigue syndrome, fibromyalgia, depression, anxiety, irritable bowel syndrome, or "stress" before anyone thinks to ask about their indoor environment.

Common symptoms of mycotoxin exposure include:

  • Fatigue and cognitive dysfunction. Persistent, unexplained exhaustion and "brain fog" — difficulty concentrating, word-finding problems, impaired short-term memory — are among the most frequently reported symptoms.
  • Respiratory problems. Chronic cough, wheezing, sinus congestion, recurrent sinus infections, and asthma exacerbation. Mold is an established trigger for asthma and allergic rhinitis, but mycotoxin exposure can cause respiratory inflammation even in non-allergic individuals.
  • Musculoskeletal pain. Joint pain, muscle aches, and generalized pain that can be mistaken for fibromyalgia or inflammatory arthritis.
  • Neurological and psychiatric symptoms. Anxiety, depression, insomnia, vertigo, numbness and tingling, and headaches. Mycotoxins — particularly trichothecenes and ochratoxin — are neurotoxic and can cross the blood-brain barrier.
  • Immune dysregulation. Recurrent infections, new-onset food sensitivities, and autoimmune-like symptoms. Gliotoxin and other immunosuppressive mycotoxins directly impair immune function.
  • Gastrointestinal symptoms. Nausea, abdominal pain, diarrhea, and appetite changes.

The key pattern is multisystem involvement — when someone presents with fatigue plus cognitive problems plus respiratory symptoms plus joint pain, and conventional workups come back normal, mold exposure should be on the differential.

Finding Hidden Mold

Visible mold is only the tip of the iceberg. Most problematic mold growth is concealed. Here is where to look and how to test:

Common hiding spots:

  • Behind drywall, especially on exterior walls or walls adjacent to bathrooms and kitchens
  • Under sinks and around plumbing penetrations
  • Inside and around HVAC systems, ductwork, and drip pans
  • Basements and crawl spaces (especially those without vapor barriers)
  • Around windows with condensation issues
  • Behind wallpaper or paneling
  • Under carpeting, particularly in basements or areas that have been wet
  • Inside washing machine gaskets and drain lines

Testing methods:

ERMI (Environmental Relative Moldiness Index) is a DNA-based test developed by the EPA that analyzes settled dust for 36 species of mold [4]. It provides a standardized score (the ERMI score) that compares your home's mold burden to a nationally representative sample. ERMI testing is more reliable than traditional methods because it detects mold species that may not be actively sporulating at the time of testing — if the DNA is in the dust, the mold has been there. ERMI scores above 5 indicate elevated mold levels, and scores above 10 indicate significant contamination. The HERTSMI-2 (a simplified subset of ERMI targeting the five most clinically significant species) is often used for follow-up testing.

Air testing (spore traps) captures airborne mold spores over a fixed time period and identifies them by species. Air testing can be useful but has significant limitations: spore counts vary dramatically with time of day, weather, HVAC operation, and occupant activity. A single air test can miss a major mold problem if conditions happen to suppress sporulation at the time of sampling. Air testing is best used alongside ERMI or as a supplement, not as a standalone assessment.

Moisture meters and thermal imaging do not detect mold directly but identify the moisture conditions that allow it to grow. An infrared camera can reveal hidden moisture behind walls and ceilings that is invisible to the eye — and where there is persistent hidden moisture, there is almost certainly mold growth.

If you suspect mold, the single most productive first step is often a thorough visual inspection combined with an ERMI dust test. If the ERMI confirms elevated mold levels, a professional inspection with moisture mapping can identify the source.

Evidence Review

WHO Guidelines on Dampness and Mould (2009)

The WHO's systematic review of evidence on indoor dampness and mold remains the most authoritative global assessment of the health effects of indoor mold exposure [1]. The guidelines concluded that there is sufficient epidemiological evidence that occupants of damp or moldy buildings are at increased risk of respiratory symptoms, respiratory infections, allergic rhinitis, and asthma development or exacerbation. The WHO estimated that dampness affects 10-50% of indoor environments across developed nations, with some surveys finding visible mold in 20-30% of homes. Critically, the guidelines noted that health effects are associated with dampness and mold in general — not only with specific mold species or specific mycotoxins — suggesting that the health impacts involve multiple biological mechanisms including allergy, infection, irritation, and toxic effects. The WHO recommended that buildings be maintained to prevent moisture accumulation as a public health priority.

Toxic Effects of Indoor Molds (Kuhn & Ghannoum, 2003)

This comprehensive review in Clinical Microbiology Reviews catalogued the known toxic effects of mycotoxins produced by indoor mold species [2]. The authors reviewed the toxicology of aflatoxins, ochratoxins, trichothecenes, fumonisins, and gliotoxin, providing dose-response data from both animal studies and clinical case reports. For trichothecenes — produced by Stachybotrys chartarum — the review documented mechanisms including inhibition of protein synthesis, DNA damage, immune suppression, and direct cytotoxicity. The authors discussed the controversy surrounding "sick building syndrome" and noted that while Koch's postulates have not been formally satisfied for indoor mold illness (it is ethically impossible to conduct controlled human exposure studies with known toxins), the combination of toxicological mechanisms, clinical case series, and epidemiological data supports a causal role for mycotoxins in chronic illness. They emphasized that immunocompromised individuals and children are particularly vulnerable.

Mycotoxins in Indoor Air (Viegas et al., 2021)

This review in Toxins specifically addressed the presence and significance of mycotoxins in indoor air — a route of exposure that has historically received less attention than dietary mycotoxin ingestion [3]. The authors documented that multiple mycotoxins (including aflatoxin B1, ochratoxin A, sterigmatocystin, and various trichothecenes) have been detected in indoor air samples and settled dust from residential, occupational, and institutional buildings. Importantly, the review discussed the stability of mycotoxins in the indoor environment: unlike the mold organisms that produce them, mycotoxins are chemically resistant to degradation and can persist in dust and on surfaces long after the producing mold colony has been killed or removed. Inhalation exposure to mycotoxin-laden dust is now recognized as a significant pathway, particularly for occupants of water-damaged buildings. The authors called for standardized methods for measuring airborne mycotoxin concentrations and for updated occupational exposure limits that account for the inhalation route.

ERMI as a Predictor of Respiratory Illness (Reponen et al., 2012)

This study in the Journal of Exposure Science and Environmental Epidemiology validated the ERMI scoring system as a predictor of childhood respiratory illness [4]. The researchers followed a birth cohort of 176 children and measured ERMI scores in their homes at age 1. Children living in homes with higher ERMI scores (indicating greater mold contamination) had significantly increased risk of developing asthma by age 7, with a dose-response relationship — each unit increase in ERMI score was associated with increased asthma risk. The study also found that the specific mold species identified by ERMI testing were more predictive of health outcomes than total spore counts obtained by traditional air sampling, supporting the use of DNA-based dust testing over conventional air testing methods. The ERMI's use of 36 mold species — including both "Group 1" species associated with water damage and "Group 2" reference species common in outdoor air — allows it to distinguish between normal outdoor mold infiltration and pathological indoor mold growth, making it a clinically useful tool for environmental assessment in patients with suspected mold illness.

References

  1. WHO Guidelines for Indoor Air Quality: Dampness and MouldWorld Health Organization. WHO Regional Office for Europe, 2009. PubMed 26726895 →
  2. Toxic Effects of Indoor MoldsKuhn DM, Ghannoum MA. Clinical Microbiology Reviews, 2003. PubMed 14754573 →
  3. Mycotoxins in Indoor Air: A ReviewViegas C, Nurme J, Piecková E, Viegas S. Toxins, 2021. PubMed 34515366 →
  4. Relative Moldiness Index as Predictor of Childhood Respiratory IllnessReponen T, Vesper S, Levin L, Johansson E, Ryan PH, Burkle J, Grinshpun SA, Zheng S, Bernstein DI, Lockey J, Villareal M, Khurana Hershey GK, LeMasters G. Journal of Exposure Science and Environmental Epidemiology, 2012. PubMed 22296745 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.